Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India

Journal of Public Health Policy

Volumn 37, Issue 3, 2016, Pages 277-299

  Atre, Sachin R ^a,b   Murray, Megan B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PUNE   (India)

Author keywords

Acquired; India; MDR TB; Pathways to care; Policy; Primary

Indexed keywords

EID: 85013228441     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2016.14     Document Type: Review

References (89)

1. Mitnick, C.D. et al (2013) Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS ONE 8(3): e58664.
2. World Health Organization. (2015) Global Tuberculosis Control Report. (WHO/HTM/TB/ 2015.22) Geneva, Switzerland: World Health Organization.
3. Udwadia, Z.F., Pinto, L.M. and Uplekar, M.W. (2010) Tuberculosis management by private practitioners in Mumbai, India: Has anything changed in two decades? PLoS ONE 5(8): e12023.
4. Uplekar, M., Pathania, V. and Raviglione, M. (2001) Private practitioners and public health: Weak links in tuberculosis control. The Lancet 358(9285): 912-916.
5. Yadav, A. et al (2012) Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh. Indian Journal of Chest Diseases and Allied Sciences 54(3): 161-163.
6. Dye, C. et al (2008) Measuring tuberculosis burden, trends and the impact of control programs. The Lancet Infectious Diseases 8(4): 233-243.
7. Kapoor, S.K., Venkat Raman, A., Sachdeva, K.S. and Satyanarayana, S. (2012) How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS ONE 7(8): e42458.
8. Satyanarayana, S. et al (2011) From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS ONE 6(9): e24160.
9. Indian Council of Medical Research. (1959) Tuberculosis in India-A National Sample Survey: 1955-58 ICMR Special Report Series, New Delhi, No. 34.
10. International Institute for Population Sciences (IIPS) and Macro International. (2007) National family health survey (NFHS-3), 2005-06, Vol I. Mumbai, India: IIPS; pp. 411-418, http://www.rchiips.org/NFHS/NFHS-3%20Data/VOL-1/India-volume-I-corrected-17oct08.pdf, accessed 14 November 2014.
11. WHO Report. (2007) Global Tuberculosis Control. Surveillance, Planning and Financing. Geneva, Switzerland, World Health Organization WHO/HTM/TB/2007.376.
12. Chadha, V.K. et al (2012) Prevalence of Pulmonary Tuberculosis among Adults in a Rural Sub-District of South India. PLoS ONE 7(8): e42625.
13. Rao, V.G. et al (2012) Prevalence of pulmonary tuberculosis - A baseline survey in central India. PLoS ONE 7(8): e43225.
14. World Health Organization. (2013) Global Tuberculosis Control Report. Geneva, Switzerland: World Health Organization.(WHO/HTM/TB/2013.13).
15. Institute of Medicine (USA). (2012) Facing the reality of drug-resistant tuberculosis in India: Challenges and potential solutions: Summary of a joint workshop by the institute of medicine, the Indian national science academy, and the Indian council of medical research. Washington DC: National Academies Press, http://www.ncbi.nlm.nih.gov/books/NBK92617/pdf/TOC.pdf, accessed 14 November 2014.
16. Bhat, J. et al (2015) Situation of drug resistant tuberculosis in Saharia tribe of central India. Indian Journal of Medical Research 141(5): 636-639.
17. Myneedu, V. et al (2015) First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi. Journal of Epidemiology & Global Health 5: 365-373.
18. Selvakumar, N. et al (2015) High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India. PLoS ONE 10(3): e0117421.
19. Salvo, F. et al (2014) Survey of tuberculosis drug resistance among Tibetan refugees in India. International Journal of Tuberculosis and Lung Disease 18(6): 655-662.
20. Das, D., Dwibedi, B. and Kar, S.K. (2014) Low levels of anti TB drug resistance in Rayagada district of Odisha, India. International Journal of Mycobacteriology 3(1): 76-78.
21. Gupta, H., Kant, S., Jain, A., Natu, S.M. and Ahluwalia, S. (2013) Initial drug resistance pattern among pulmonary tuberculosis patients. Indian Journal of Tuberculosis 60(3): 154-161.
22. Yadav, R., Sethi, S., Dhatwalia, S., Gupta, D., Mewara, A. and Sharma, M. (2013) Molecular characterization of drug resistance in Mycobacterium tuberculosis isolates from North India. International Journal of Tuberculosis and Lung Disease 17(2): 251-257.
23. Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among category II pulmonary tuberculosis patients. Indian Journal of Medical Research 133(3): 312-315.
24. Sharma, S.K. et al (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. Indian Journal of Medical Research 133(3): 308-311.
25. Ramachandran, R. et al (2009) Surveillance of drug-resistant tuberculosis in the state of Gujarat. India International Journal of Tuberculosis and Lung Disease 13(9): 1154-1160.
26. D'Souza, D.T. et al (2009) High levels of multidrug resistant tuberculosis in new and treatmentfailure patients from the Revised National Tuberculosis Control Program in an urban metropolis (Mumbai) in Western India. BMC Public Health 9: 211.
27. Joseph, B.V. et al (2009) Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India. International Journal of Tuberculosis and Lung Disease 13(4): 494-499.
28. Jain, A., Mondal, R., Prasad, R., Singh, K. and Ahuja, R.C. (2008) Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian Journal of Medical Research 128(3): 300-306.
29. Joseph, M.R., Shoby, C.T., Amma, G.R., Chauhan, L.S. and Paramasivan, C.N. (2007) Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. International Journal of Tuberculosis and Lung Disease 11(4): 443-449.
30. Anuradha, B. et al (2006) Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003. International Journal of Tuberculosis and Lung Disease 10(1): 58-62.
31. Dhingra, V.K., Rajpal, S., Bhalla, P., Yadav, A., Jain, S.K. and Hanif, M. (2003) Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Journal of Communicable Diseases 35(2): 82-89.
32. Negi, S.S., Gupta, S. and Lal, S. (2003) Drug resistance in tuberculosis in Delhi: A 2 year profile (2001-2002). Journal of Communicable Diseases 35(2): 74-81.
33. Shah, A.R., Agarwal, S.K. and Shah, K.V. (2002) Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. International Journal of Tuberculosis and Lung Disease 6(12): 1098-1101.
34. Paramasivan, C.N., Venkataraman, P., Chandrasekaran, V., Bhat, S. and Narayanan, P.R. (2002) Surveillance of drug resistance in tuberculosis in two districts of South India. International Journal of Tuberculosis and Lung Disease 6(6): 479-484.
35. Although India has 29 States and 7 Union territories as of 2014, at the time of analysis data was only available for 28 States.
36. Government of India Planning Commission data book. (2014) http://planningcommission.nic. in/data/datatable/0814/comp-databook.pdf, accessed 9 November 2014.
37. Government of India - TB India. (2014) Revised National TB Control Program Annual Status Report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20INDIA%202014.pdf, accessed 15 April 2014.
38. Warner, D.F. and Mizrahi, V. (2006) Tuberculosis chemotherapy: The influence of bacillary stress and damage response pathways on drug efficacy. Clinical Microbiology Review 19(3): 558-570.
39. WHO/IUATLD. (2004) Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in theWorld. Geneva, Switzerland:World Health Organization. Report No.3.
40. Dye, C. et al (2002) Erasing the world's slow stain: Strategies to beat multi drug-resistant tuberculosis. Science 295(5562): 2042-2046.
41. Billington, O.J., McHugh, T.D. and Gillespie, S.H. (1999) Physiological cost of rifampicin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 43(8): 1866-1869.
42. Nardell, E. and Dharmadhikari, A. (2010) Turning off the spigot: Reducing drug-resistant tuberculosis transmission in resource-limited settings. International Journal of Tuberculosis and Lung Disease 14(10): 1233-1243.
43. Zhao, M. et al (2009) Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS ONE 4(2): e4370.
44. Grandjean, L. et al (2015) Transmission of multidrug-resistant and drug-susceptible tuberculosis within households: A prospective cohort study. PLoS Medicine 12(6): e1001843.
45. Cohen, T. and Murray, M. (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nature Medicine 10(10): 1117-1121.
46. Cohen, T., Sommers, B. and Murray, M. (2003) The effect of drug resistance on the fitness of Mycobacterium tuberculosis. The Lancet Infectious Diseases 31: 13-21.
47. Waisbord, S. and Zimicki, S. http://www.popline.org/node/264997, accessed 9 November 2014.
48. Weiss, M., Auer, C., Somma, D. and Abouihia, A (2006) Gender and tuberculosis: Cross-site analysis and implications of a multi-country study in Bangladesh, India, Malawi and Colombia. Special Programme for Research and Training in Tropical Diseases (UNICEF/UNDP/World Bank/WHO), TDR/SDR/SEB/RP/06.1. Geneva, Switzerland: WHO. Report Series No. 3, http:// www.who.int/tdr/publications/documents/sebrep3.pdf, accessed 5 May 2014.
49. Atre, S. et al (2011) Gender and community views of stigma and tuberculosis in rural Maharashtra, India. Global Public Health 6(1): 56-71.
50. Somma, D. et al (2008) Gender and socio-cultural determinants of TB-related stigma in Bangladesh, India, Malawi and Colombia. International Journal of Tuberculosis and Lung Disease 12(7): 856-866.
51. Jaramillo, E. (1998) Pulmonary tuberculosis and health-seeking behaviour: how to get a delayed diagnosis in Cali, Colombia. Tropical Medicine & International Health 3(2): 138-144.
52. Liefooghe, R. et al (1997) From their own perspectiveA Kenyan Community's Perception of Tuberculosis. Tropical Medicine & International Health 2(8): 809-821.
53. Portero, L.J. and Rubio, M. (2003) Private practitioners and tuberculosis control in the Philippines: Strangers when they meet? Tropical Medicine & International Health 8(4): 329-335.
54. Pinto, L.M. and Udwadia, Z.F. (2010) Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health 10: 357.
55. Jaggarajamma, K., Balambal, R. and Muniyandi, M. (2009) Perceptions of tuberculosis patients about private providers before and after implementation of Revised National Tuberculosis Control Program. Indian Journal of Tuberculosis 56(4): 185-190.
56. Uplekar, M. et al (1998) Tuberculosis patients and practitioners in private clinics in India. International Journal of Tuberculosis and Lung Disease 2(4): 324-329.
57. Pathania, V., Almeida, J. and Kochi, A. (1997) TB Patients and Private for Profit Health Care Providers in India. Geneva, Switzerland: World Health Organization, WHO/TB/ 97.223.1997.
58. Srivastava, D.K. et al (2011) An assessment of knowledge and practices regarding tuberculosis in the Context of RNTCP among non-allopathic practitioners in Gwalior District. Online Journal of Health and Allied Sciences 10(2): 5.
59. Bhargava, A., Pinto, L. and Pai, M. (2011) Mismanagement of tuberculosis in India: Causes, consequences, and the way forward. Hypothesis 9(1): e7.
60. Datta, K., Bhatnagar, T. and Murhekar, M. (2010) Private practitioners' knowledge, attitude and practices about tuberculosis, Hooghly district India. Indian Journal of Tuberculosis 57(4): 199-206.
61. Uplekar, M., Juvekar, S. and Morankar, S. (1996) Tuberculosis patients and practitioners in private clinics, Bombay [Research Newsletter]. Foundation for Research in Community Health.
62. Jagota, P. (1998) Case finding policy for national tuberculosis program. Indian Journal of Tuberculosis 45(1): 3-7.
63. Central TB Division (CTD). (2012) Guidelines on programmatic management of drug resistant TB (PMDT) in India. Ministry of Health&FamilyWelfare, Nirman Bhavan, New Delhi, http:// tbcindia.gov.in/WriteReadData/l892s/8320929355Guidelines%20for%20PMDT%20in% 20India%20-%20May%202012.pdf, accessed 21 February 2016.
64. Government of India - TB India. (2015) Revised National TB Control Program Annual Status Report, New Delhi, http://tbcindia.gov.in/showfile.php?lid=3166, accessed 25 November 2015.
65. Sachdeva, K. (2013) Management of tuberculosis: Indian Guidelines 2013, http://www.apiindia.org/medicine-update-2013/chap105.pdf, accessed 25 November 2015.
66. Census of India (State Census). (2011) http://www.census2011.co.in/states.php, accessed on 25 November 2015.
67. Chadha, S. et al (2011) Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLoS ONE 6(11): e26659.
68. Global Alliance for TB drug development. (2007) Pathway to Patients: Charting the Dynamics of the Global TB Drug Market. New York: TB Alliance.
69. Greaves, F., Ouyang, H., Pefole, M, MacCarthy, S. and Cash, R.A. (2007) Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India. International Journal of Tuberculosis and Lung Disease 11(1): 110-112.
70. Pathania, V.S. (2001) Why the Indian TB control program must stop ignoring private practitioners. International Journal of Tuberculosis and Lung Disease 5(2): 201-203.
71. Uplekar, M.W. and Shepard, D.S. (1991) Treatment of tuberculosis by private general practitioners in India. Tubercle 72(4): 284-290.
72. Gupta, S., Gupta, S. and Behera, D. (2011) Reasons for interruption of anti-tubercular treatment as reported by patients with tuberculosis admitted in a tertiary care institute. Indian Journal of Tuberculosis 58(1): 11-17.
73. Atre, S. (2015) Notification of multidrug-resistant tuberculosis cases and their treatment outcomes from the private sector. International Journal of Tuberculosis and Lung Disease 19(9): 1126.
74. Sharma, S. and Mohan, A. (2006) Multidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis control. Chest 130(1): 261-272.
75. Farmer, P. and Kim, J.Y. (1998) Community based approaches to the control of multidrugresistant tuberculosis: Introducing 'DOTS-plus'. BMJ 317(7159): 671-674.
76. Atre, S., D'Souza, D.T.B., Dholakia, Y.N. and Mistry, N.F. (2007) Observations on categorization of new TB cases: Implications for controlling drug resistance. International Journal of Tuberculosis and Lung Disease 11(10): 1152-1153.
77. Mphahlele, M. et al (2008) Pyrazinamide resistance among South African multidrugresistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 46(10): 3459-3464.
78. Khurram, M., Khaar, H.T. and Fahim, M. (2012) Multidrug-resistant tuberculosis in Rawalpindi, Pakistan. The Journal of Infection in Developing Countries 6(1): 29-32.
79. Whitfield, M.G. et al (2015) A global perspective on pyrazinamide resistance: Systematic review and meta-analysis. PLoS ONE 10(7): e0133869.
80. Otu, A., Umoh, V., Habib, A., Ameh, S., Lawson, L. and Ansa, V. (2013) Drug Resistance among Pulmonary Tuberculosis Patients in Calabar. Pulmonary Medicine, doi:101155/2013/ 235190.
81. Franke, M. et al (2015) Counting pyrazinamide in regimens for multidrug - Resistant tuberculosis. Annals of American Thoracic Society 12(5): 674-679.
82. Laniado-Laborin, R. (2010) Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered. Expert Review of Respiratory Medicine 4(2): 143-146.
83. Suárez, P. et al (2002) Feasibility and cost - effectiveness of standardized second-line drug treatment for chronic tuberculosis patients: A national cohort study in Peru. The Lancet 359(9322): 1980-1989.
84. Park, S., Lee, W.C., Lee, D.H., Mitnick, C.D., Han, L. and Seung, K.J. (2004) Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. International Journal of Tuberculosis and Lung Disease 8(3): 361-368.
85. Mitnick, C. et al (2003) Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. The New England Journal of Medicine 348: 119-128.
86. Leimane, V. et al (2005) Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: A retrospective cohort study. The Lancet 365(9456): 318-326.
87. Government of India. TB India. (2013) Revised national TB control program annual status report, New Delhi, http://www.tbcindia.nic.in/pdfs/TB%20India%202013.pdf, accessed 15 April 2014.
88. World Bank. (2013) Public health expenditure data, http://data.worldbank.org/indicator/SH. XPD.PUBL.ZS, accessed 5 March 2014.
89. Escombe, A.R. et al (2013) Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med 6(3): e1000043.